This meta-analysis summarizes the comparative effects of mortality and BPD ventilation strategies delivered within 24 hours of birth to neonates younger than 33 weeks’ gestational age who had not been intubated.
This randomized clinical trial assesses whether prophylactic early high-dose recombinant human erythropoietin (rhEPO) improves neurodevelopmental outcome for preterm infants at 2 years’ corrected age.
This population epidemiology study used neonatal registry data to characterize trends in maternal and neonatal care, and morbidity and mortality of extremely preterm infants between 1993 and 2012.
This post hoc analysis of data from a trial comparing lower and higher oxgen saturation targets among extremely preterm infants investigated associations between episodes of hypoxemia or bradycardia and late death or neurodevelopmental disability.
This population-based cohort study reports that screening echocardiography before day 3 of life to identify patent ductus arteriosus among extremely preterm infants was associated with lower in-hospital mortality and likelihood of pulmonary hemorrhage.
This follow-up study to a randomized trial determined that antenatal magnesium sulfate was not associated with improved neurological, cognitive, academic, or behavioral outcomes at school age.
Leuchter and coauthors conducted a randomized trial to determine if there is an association between early high-dose recombinant human erythropoietin treatment in preterm infants and biomarkers of encephalopathy of prematurity on magnetic resonance imaging (MRI) at term-equivalent age.
Benjamin and colleagues evaluate the safety and effect of fluconazole prophylaxis in reducing candidiasis and mortality in a randomized blinded, placebo-controlled trial of 361 premature US infants.